ES2041647T3 - Metodo para producir un compuesto de oseinahidroxiapatita. - Google Patents

Metodo para producir un compuesto de oseinahidroxiapatita.

Info

Publication number
ES2041647T3
ES2041647T3 ES198787101136T ES87101136T ES2041647T3 ES 2041647 T3 ES2041647 T3 ES 2041647T3 ES 198787101136 T ES198787101136 T ES 198787101136T ES 87101136 T ES87101136 T ES 87101136T ES 2041647 T3 ES2041647 T3 ES 2041647T3
Authority
ES
Spain
Prior art keywords
oseinahidroxiapatita
compound
produce
osuros
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787101136T
Other languages
English (en)
Spanish (es)
Inventor
Thea Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robapharm AG
Original Assignee
Robapharm AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robapharm AG filed Critical Robapharm AG
Application granted granted Critical
Publication of ES2041647T3 publication Critical patent/ES2041647T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/84—Bones; tendons; teeth; cartilage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
ES198787101136T 1986-08-05 1987-01-28 Metodo para producir un compuesto de oseinahidroxiapatita. Expired - Lifetime ES2041647T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3626414A DE3626414C2 (de) 1986-08-05 1986-08-05 Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
ES2041647T3 true ES2041647T3 (es) 1993-12-01

Family

ID=6306689

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787101136T Expired - Lifetime ES2041647T3 (es) 1986-08-05 1987-01-28 Metodo para producir un compuesto de oseinahidroxiapatita.

Country Status (20)

Country Link
US (1) US4919931A (US08197722-20120612-C00042.png)
EP (1) EP0255565B1 (US08197722-20120612-C00042.png)
JP (1) JPS6344527A (US08197722-20120612-C00042.png)
KR (2) KR880002897A (US08197722-20120612-C00042.png)
CN (1) CN1028237C (US08197722-20120612-C00042.png)
AR (1) AR242589A1 (US08197722-20120612-C00042.png)
AT (1) ATE77239T1 (US08197722-20120612-C00042.png)
AU (1) AU604014B2 (US08197722-20120612-C00042.png)
CA (1) CA1289878C (US08197722-20120612-C00042.png)
DE (2) DE3626414C2 (US08197722-20120612-C00042.png)
DK (1) DK175488B1 (US08197722-20120612-C00042.png)
ES (1) ES2041647T3 (US08197722-20120612-C00042.png)
FI (1) FI91877C (US08197722-20120612-C00042.png)
GR (1) GR3005579T3 (US08197722-20120612-C00042.png)
HU (1) HU205373B (US08197722-20120612-C00042.png)
IE (1) IE59916B1 (US08197722-20120612-C00042.png)
IL (1) IL82213A (US08197722-20120612-C00042.png)
NO (1) NO173786C (US08197722-20120612-C00042.png)
PT (1) PT84693B (US08197722-20120612-C00042.png)
ZA (1) ZA872701B (US08197722-20120612-C00042.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861590A (en) * 1986-09-25 1989-08-29 Colgate-Palmolive Company Sustained release fluoride and calcium composition
US4859467A (en) * 1986-09-25 1989-08-22 Colgate-Palmotive Company Sustained release fluoride composition
JPH02149618A (ja) * 1988-11-30 1990-06-08 Kobe Steel Ltd 加工性に優れた高強度熱延鋼板の製造方法
CN1045719C (zh) * 1993-04-10 1999-10-20 北京市西城区华新生化技术研究所 口服接骨和治骨质疏松液
EP0635518B1 (en) * 1993-07-23 2003-10-08 Kato, Yukio, Prof. New chondrocyte protein
EP0777491B1 (de) * 1994-08-23 2004-11-17 Deutsche Gelatine-Fabriken Stoess AG Verwendung von geschmacksneutralem, hydrolysiertem kollagen und mittel enthaltend dasselbe
US5788941A (en) * 1996-01-31 1998-08-04 Steris Corporation Method of sterilization of bone tussue
JPH09238291A (ja) * 1996-02-29 1997-09-09 Sony Corp メニュー操作方法及び電子機器及びテレビジョン受像機
NL1020729C2 (nl) * 2002-05-31 2003-12-02 Gelatine Smits Beheer B V Calciumbevattende samenstelling, werkwijze voor het bereiden daarvan, en farmaceutisch preparaat op basis van de samenstelling.
CN1212126C (zh) * 2002-07-09 2005-07-27 中国科学院长春应用化学研究所 纳米羟基磷灰石补钙剂
JP4369969B2 (ja) * 2007-10-26 2009-11-25 株式会社アールビーエス 生体適合性材料並びにその製造方法
DK2699249T3 (en) 2011-04-19 2017-01-09 Bioiberica cartilage Product
RU2478394C1 (ru) * 2011-11-23 2013-04-10 Федеральное государственное бюджетное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова" Министерства здравоохранения и социального развития Российской Федерации Биоматериал для возмещения дефектов костей и способ его получения
EP3041482B1 (en) * 2013-09-05 2021-06-09 Waitaki Biosciences High osteocalcin microcrystalline hydroxyapatite for calcium supplement

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE894895C (de) * 1950-03-06 1953-10-29 Albert Dr Reissner Verfahren zur Herstellung eines Praeparates zur Anregung der Zahnerhaltung
BE650626A (US08197722-20120612-C00042.png) * 1962-02-28 1900-01-01
USRE28093E (en) * 1962-02-28 1974-07-30 Wound-healing cartilage powder
US3400199A (en) * 1965-02-26 1968-09-03 Leslie L. Balassa Wound-healing cartilage powder
DE2425266A1 (de) * 1974-05-24 1975-11-27 Lothar Tischmann Zum einnehmen bestimmtes naehr- und heilmittel aus tierischer knochen-substanz und verfahren zu seiner herstellung
DE2840064C2 (de) * 1978-09-14 1989-09-21 Hans Dr.med. Dr.med.dent. 8000 München Scheicher Verfahren zur Herstellung von Knochenkontaktschichten
US4232425A (en) * 1980-01-15 1980-11-11 Darling & Company Method of producing stabilized bone
US4455256A (en) * 1981-05-05 1984-06-19 The Regents Of The University Of California Bone morphogenetic protein
US4294753A (en) * 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process
ZA816771B (en) * 1980-10-07 1982-10-27 Lensfield Prod Ltd Protein production
US4444752A (en) * 1982-09-13 1984-04-24 Lescarden Ltd. Method for treating progressive systemic sclerosis
US4436720A (en) * 1983-03-04 1984-03-13 Pakhomov Gennady N Granulated treatment-and-prophylactic dental preparation possessing anticarious effect
NZ210699A (en) * 1984-01-04 1989-06-28 Int Genetic Eng Isolation of an osteogenic protein of the p3 immunologically related family
DE3409372A1 (de) * 1984-03-14 1985-09-19 Dr. Ruhland Nachf. GmbH, 8425 Neustadt Material zum vitalisieren von implantatoberflaechen
DE3422466C1 (de) * 1984-06-16 1986-03-20 Lothar 6750 Kaiserslautern Tischmann Verfahren zum Herstellen eines eßbaren, proteinhaltigen Knochenmehlpräparates aus frischen Tierknochen
US4620327A (en) * 1984-07-05 1986-11-04 Caplan Arnold I Process of adapting soluble bone protein for use in stimulating osteoinduction

Also Published As

Publication number Publication date
AR242589A1 (es) 1993-04-30
AU604014B2 (en) 1990-12-06
AU7157787A (en) 1988-02-11
GR3005579T3 (US08197722-20120612-C00042.png) 1993-06-07
ATE77239T1 (de) 1992-07-15
DE3626414C2 (de) 1994-11-10
FI91877C (fi) 1994-08-25
CA1289878C (en) 1991-10-01
NO871599L (no) 1988-02-08
HUT44047A (en) 1988-01-28
JPS6344527A (ja) 1988-02-25
IL82213A0 (en) 1987-10-30
EP0255565B1 (en) 1992-06-17
FI871670A0 (fi) 1987-04-15
PT84693B (pt) 1990-06-29
PT84693A (en) 1987-05-01
NO173786B (no) 1993-10-25
DK175488B1 (da) 2004-11-08
DK196387D0 (da) 1987-04-15
KR880002897A (ko) 1988-05-12
IL82213A (en) 1991-08-16
FI871670A (fi) 1988-02-06
NO173786C (no) 1994-02-02
US4919931A (en) 1990-04-24
CN1028237C (zh) 1995-04-19
HU205373B (en) 1992-04-28
DE3626414A1 (de) 1988-02-11
EP0255565A3 (en) 1990-01-31
IE870983L (en) 1988-02-05
JPH0558606B2 (US08197722-20120612-C00042.png) 1993-08-27
DE3779829T2 (de) 1993-01-14
ZA872701B (en) 1987-11-25
EP0255565A2 (en) 1988-02-10
NO871599D0 (no) 1987-04-15
FI91877B (fi) 1994-05-13
DK196387A (da) 1988-02-06
KR880002534A (ko) 1988-05-09
DE3779829D1 (de) 1992-07-23
IE59916B1 (en) 1994-04-20
KR960009651B1 (en) 1996-07-23
CN87102744A (zh) 1988-02-17

Similar Documents

Publication Publication Date Title
ES2041647T3 (es) Metodo para producir un compuesto de oseinahidroxiapatita.
DK155686A (da) Parathyroidhormonholdigt praeparat
DE3752113D1 (de) Target zur Erzeugung von Röntgenstrahlen
DE3772429D1 (de) Pharmazeutisches praeparat zur behandlung von peridontalkrankheiten.
BR9107206A (pt) Processo para produzir uma variante de proteina que evoca uma resposta imunogenica diminuida em animais,produtos obtidos,composicao e uso
PT99998A (pt) Metodo para a preparacao e utilizacao da 1-alfa,24-di-hidroxi-vitamina d2
DE3873855D1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
IT8748394A0 (it) E la prevenzione della osteoporosi composizione di fluoro e calcio a e simili affezioni ossee lento rilascio, per il trattamento
DE3783280D1 (de) Teilweise retro-invertierte analoge des tuftsin, methode zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten.
SE8505488L (sv) Isosilybinfri silibinin
AT383123B (de) Verfahren zur herstellung von neuen (+)-catechin- alpha- monohydrat
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
DE3763286D1 (de) T-geschiebe zur loesbaren befestigung von zahnprothesen.
DE3781767D1 (de) Verfahren zur herstellung einer extra-oralen zahnrestauration.
DE3675115D1 (de) Verwendung von verbindungen zur herstellung eines medikaments fuer die behandlung von grauem star.
ATE247474T1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
IT1233632B (it) Impianto di disinfezione, in particolare per manipoli di riuniti dentali
DE3855159D1 (de) Thienotricyclen zur Behandlung von Erkrankungen der Bronchien
DK344386D0 (da) Fremgangsmaade til produkttion af seksualprodukter i dyr
ES2038204T3 (es) Procedimiento para la preparacion de productos intermedios de carbaciclina opticamente activos.
ATA40997A (de) Verwendung von humanem alpha1-sauren glycoprotein zur herstellung einer pharmazeutischen präparation
IT8620177A0 (it) Metodo e mezzi per la realizzazione di protesi dentali fisse quali ponti.
IT9067492A0 (it) Procedimento per la purificazione di succo di datteri estratto senza additivi.
IT211497Z2 (it) Camera di sterilizzazione particolarmente per odontoiatria.
ATE79541T1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 255565

Country of ref document: ES